Navigation Links
Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
Date:6/11/2008

Researchers at The Johns Hopkins University are participating in a large multi-center prospective trial to study the link between the IGF2 biomarker and colorectal cancer.

"If the power of this risk marker shown in earlier clinical studies is confirmed by the large prospective trial now underway, it can potentially change the way populations are screened for colon cancer," said Graham Colditz, MD, DrPH, Associate Director of Prevention and Control, Alvin J. Siteman Cancer Center. "The test may identify people who should be screened earlier in life and more frequently, while also identifying individuals who can start screening later than what is now recommended, thus serving as a tool to help physicians in developing targeted monitoring plans and shifting resources to the people most likely to develop colon cancer."

"Colorectal cancer is the second most deadly cancer claiming more than 52,000 lives in 2007 in the U.S., with treatment costs for colorectal cancer estimated to exceed $8 billion annually," Lakey continued. "We believe our risk assessment test will be easily incorporated into the routine management of colorectal cancer. When used in conjunction with colonoscopy screening, our test has the potential to reduce colorectal cancer incidence as well as reduce associated colorectal cancer treatment costs in a U.S. clinical market size of more than 81 million people."

About Orion Genomics

Orion Genomics develops epigenetic research tools and molecular diagnostic products to detect cancer at its earliest stages and to aid in appropriate therapy selection. The company has active biomarker discovery programs in cancers of the bladder, breast, lung, ovaries and colon. Orion Genomics is located in the Center for Emerging Technologies in St. Louis. For more information, visit http://www.oriongenomics.com.


'/>"/>
SOURCE Orion Genomics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
2. Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer
3. Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
4. Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Companys MicroRNA Technology
5. Columbia University Medical Center and Rosetta Genomics Announce Columbia Universitys Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica
6. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
7. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
9. Grocery Manufacturers Association: Study Signals Progress in Battle Against Obesity
10. Annual Conference on Vaccine Research to Highlight Not Only Health Benefits But Also Economic Gains
11. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Wash. , Dec. 19, 2014  Advanced ... stage development company engaged primarily in the development ... and therapeutic applications, today announced that a Life ... has been awarded for which AMIC is the ... State University (WSU) for the proposal titled "Optimized ...
(Date:12/19/2014)... 2014 In today,s rapidly changing, highly ... tools are essential for survival. The world is ... desires, preferences, and unmet needs are evolving rapidly. ... across all industries are continually searching for innovative ... adoption of new market research techniques like mobile ...
(Date:12/19/2014)... , Dec. 18, 2014 Somewhere between ... hearing health was forgotten. But Audicus , a ... hear better this new year. Hearing loss ... the aging population, though it is often unaddressed. Forty-eight ... four has a hearing aid, mainly due to price. ...
Breaking Medicine Technology:Advanced Medical Isotope Corporation Awarded LSDF Grant As Commercialization Partner 2Advanced Medical Isotope Corporation Awarded LSDF Grant As Commercialization Partner 3Study Uncovers New Tools and Techniques for Understanding Consumer Decision Making 2Audicus Will Help People Resolve to Hear Better in 2015 2
... 20 Valor Medical, an emerging medical,device company in ... of Neucrylate AN for treatment of cerebral aneurysms was ... The treatment was under the,guidance of a clinical protocol ... Dr. Pakbaz stated that the patient,s aneurysm was ...
... Ages, ALEXANDRIA, Va., March 19 A ... 18, 2008) reports that pelvic,floor muscle training, in ... incontinence in women. According to the American,Physical Therapy ... physical therapist can help patients manage, if not,alleviate, ...
Cached Medicine Technology:New Study Reports That Physical Therapy Treatment Resolves Symptoms of Urinary Incontinence in Women 2New Study Reports That Physical Therapy Treatment Resolves Symptoms of Urinary Incontinence in Women 3New Study Reports That Physical Therapy Treatment Resolves Symptoms of Urinary Incontinence in Women 4
(Date:12/20/2014)... San Francisco, CA (PRWEB) December 20, 2014 ... a Social Innovation company just launched first birthday focused ... the services, “MERRY BIRTHDAY MESSAGE” launched in both US ... , MERRY BIRTHDAY MESSAGE : http://merrybirthday.net/message/ , ... launching for everyone’s birthday around the world. , Features, ...
(Date:12/20/2014)... (PRWEB) December 20, 2014 Developers of ... release of a new plugin for Final Cut Pro ... , “TranSlice Volume 5 allows users to create hand ... it.” Said Christina Austin, CEO of Pixel Film Studios. ... of professionalism while maintaining an easy to use interface.” ...
(Date:12/20/2014)... Parker & Sons, Inc. a focused and ... in contractor services announces reaching a milestone by providing ... of Arizona. Parker and Sons is comprised of a ... make customer service the number one priority. The company ... with one service vehicle and has since grown to ...
(Date:12/19/2014)... 20, 2014 It’s very easy to become ... that is put to the wayside until Christmas and the ... that travel “itch” and that burning desire to just escape ... on their journey to Telluride with a no-fuss, affordable package. ... and from the resort, and ensure that all accommodations are ...
(Date:12/19/2014)... FL (PRWEB) December 19, 2014 ... Revitalizing Bedsheets are now available. Celliant, the world’s ... both sheets and pillowcases. , There are a ... proven additional circulation, increased oxygenation and balanced body ... faster healing and pain relief; enhanced athletic performance; ...
Breaking Medicine News(10 mins):Health News:Atore, Inc. Releasing the First Birthday Portal 2Health News:Pixel Film Studios released a new transition entitled TranSlice Volume 5 exclusively for Final Cut Pro X 2Health News:Parker & Sons Announces Reaching A Milestone By Providing 40 Years Of Dedicated Contractor Services For Homeowners Of Arizona 2Health News:Parker & Sons Announces Reaching A Milestone By Providing 40 Years Of Dedicated Contractor Services For Homeowners Of Arizona 3Health News:Days Inn Montrose Colorado Delivers Last Minute Holiday Season Ski Getaway Accommodations 2Health News:Energy Textiles Launches Celliant Revitalizing Bedsheets 2
... Aero Financial, Inc, a strategic advisory and finance & ... been retained as a strategic consulting partner by Only ... information and nutrition products.Pursuant to the consulting agreement, Aero ... of the company,s growth plans, including:, ...
... Industry Professionals Available for Comment on Health Reform under Obama ... ... LLP today published a brief entitled 10 Minutes on Health ... alter the employer-based insurance system, the advantages of universal healthcare ...
... Why? , ... (PRWEB) January 22, 2009 -- Web 2.0, Health 2.0, ... are appearing more and more in the healthcare space and many hospital ... their marketing plans as another way to increase market share and build ...
... SEATTLE, Jan. 22 Cell Therapeutics, Inc. (CTI),(Nasdaq and ... by,Esmaeli, et al. online on January 15, 2009 in ... agent Zevalin (ibritumomab,tiuxetan) in a front-line setting for patients ... involved the conjunctiva or orbit,produced a complete response rate ...
... HealthSystem,Consortium (UHC) today announced that after a competitive ... measurement services to Avatar,International and Press Ganey Associates, ... with options to extend. The agreements are effective ... Under the agreements, Avatar and Press Ganey ...
... Gen. Eric K. Shinseki took the oath of office ... assuming the leadership of the Department of Veterans Affairs ... am addressing from my first day in office is ... century organization focused on the Nation,s Veterans as its ...
Cached Medicine News:Health News:Aero Financial Retained as Strategic Consultant by Only Natures Finest(TM) 2Health News:Media Alert: PricewaterhouseCoopers Publishes Brief on the Impact of Government Health Reform on U.S. Employers 2Health News:Media Alert: PricewaterhouseCoopers Publishes Brief on the Impact of Government Health Reform on U.S. Employers 3Health News:Media Alert: PricewaterhouseCoopers Publishes Brief on the Impact of Government Health Reform on U.S. Employers 4Health News:Hope is Not a Strategy: Neither is Web 2.0 for a Hospital 2Health News:Hope is Not a Strategy: Neither is Web 2.0 for a Hospital 3Health News:Treatment with the Zevalin(R) Therapeutic Regimen as Sole Therapy Produces 83 Percent Complete Response Rate in Mucosa-Associated Lymphoid Tissue (MALT) Orbital Lymphoma 2Health News:Treatment with the Zevalin(R) Therapeutic Regimen as Sole Therapy Produces 83 Percent Complete Response Rate in Mucosa-Associated Lymphoid Tissue (MALT) Orbital Lymphoma 3Health News:Treatment with the Zevalin(R) Therapeutic Regimen as Sole Therapy Produces 83 Percent Complete Response Rate in Mucosa-Associated Lymphoid Tissue (MALT) Orbital Lymphoma 4Health News:University HealthSystem Consortium Announces Dual Award for Patient Satisfaction Measurement Services 2Health News:Shinseki Sworn In, Vows 21st Century Service to Veterans 2
4 mm blade. Flat handle....
9 mm button end blade. 15 mm long backcutting blade. Angled at 45 degrees. Flat handle. Designated most popular model or size....
10 mm blade, angled left. Flat handle....
4 mm blade. Bayonet. Flat handle....
Medicine Products: